Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]GP1 PET/CT in Thromboembolism
NCT02864810Phase 1Completed
- Sponsor
- The Asan Foundation
- Start
- Aug 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 18F-GP1 in thromboembolism, sponsored by The Asan Foundation. Primary endpoint: Detection rate of thromboembolic focus/foci with [18F]GP1 PET/CT at 6 months. Started Aug 2016; status: completed.
02
Drugs
18F-GP1
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02864810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02864810.